These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2503788)

  • 21. [Protective efficacy of some inactivated oral bacterial vaccines].
    Negretti F
    Ann Sclavo; 1972; 14(5):591-8. PubMed ID: 4205298
    [No Abstract]   [Full Text] [Related]  

  • 22. [The appearance of specific IgG and IgA antibodies to Streptococcus pneumoniae in serum and lung lavage fluid of mice after the administration of different antigens. 2. IgG and IgA antibody detection after intraperitoneal, aerosol and oral immunization with Streptococcus pneumoniae].
    Schumann V; Tischner H; Noack K; Schröder R; Pohl WD
    Z Erkr Atmungsorgane; 1988; 171(1):75-81. PubMed ID: 2973690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The antigenic activity of vaccines made from opportunistic microorganisms in an experiment to immunize animals by oral and combined methods].
    Efremova VN; Poliachenko VM; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):40-3. PubMed ID: 1441812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the origins of biliary immunoglobulins in rats.
    Manning RJ; Walker PG; Carter L; Barrington PJ; Jackson GD
    Gastroenterology; 1984 Jul; 87(1):173-9. PubMed ID: 6539266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The appearance of specific IgG and IgA antibodies to Streptococcus pneumoniae in serum and in lung lavage fluid of mice after the administration of different antigens. 1. Development of an enzyme immunoassay (EIA) for the detection of specific IgG and IgA antibodies to Streptococcus pneumoniae].
    Schumann V; Tischner H; Noack K; Schröder R; Pohl WD
    Z Erkr Atmungsorgane; 1988; 171(1):67-74. PubMed ID: 3057752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2-5-year-old children.
    Ahmed A; Li J; Shiloach Y; Robbins JB; Szu SC
    J Infect Dis; 2006 Feb; 193(4):515-21. PubMed ID: 16425130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum antibodies and immunoglobulins in smokers and nonsmokers.
    Andersen P; Pedersen OF; Bach B; Bonde GJ
    Clin Exp Immunol; 1982 Feb; 47(2):467-73. PubMed ID: 7042142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Appearance of IgG and IgA antibodies in human bile after tetanus toxoid immunization.
    Hansen PG; Hennessy EJ; Blake H; Clancy RL; Kamath R; Molenaar C; Cripps AW; Jackson GD
    Clin Exp Immunol; 1989 Aug; 77(2):215-20. PubMed ID: 2776360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cell preparation of Enterococcus faecalis strain EC-12 stimulates the luminal immunoglobulin A secretion in juvenile calves.
    Tsuruta T; Inoue R; Tsukahara T; Matsubara N; Hamasaki M; Ushida K
    Anim Sci J; 2009 Apr; 80(2):206-11. PubMed ID: 20163592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli.
    Evans DG; Graham DY; Evans DJ
    Gastroenterology; 1984 Oct; 87(4):934-40. PubMed ID: 6381216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
    Tobias J; Lebens M; Bölin I; Wiklund G; Svennerholm AM
    Vaccine; 2008 Feb; 26(6):743-52. PubMed ID: 18191006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standardization of Escherichia coli oral vaccines.
    Felsenfeld O
    Dev Biol Stand; 1976; 33():113-7. PubMed ID: 821801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated levels of immunoglobulins and immune complexes in the bile of patients with primary sclerosing cholangitis.
    Alberti-Flor JJ; de Medina M; Jeffers L; Schultz DR; Schiff ER
    Am J Gastroenterol; 1986 May; 81(5):325-8. PubMed ID: 3706245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response.
    Verdonck F; Cox E; Van der Stede Y; Goddeeris BM
    Vaccine; 2004 Oct; 22(31-32):4291-9. PubMed ID: 15474721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial.
    McKenzie R; Walker RI; Nabors GS; Van De Verg LL; Carpenter C; Gomes G; Forbes E; Tian JH; Yang HH; Pace JL; Jackson WJ; Bourgeois AL
    Vaccine; 2006 May; 24(18):3735-45. PubMed ID: 16095766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
    Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS
    Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local and systemic antibody response in infants after oral administration of inactivated enteropathogenic E. coli serotype O111 and O55.
    Lodinová-Zádníková R; Korych B; Gajdostíková K
    Folia Microbiol (Praha); 1990; 35(2):155-62. PubMed ID: 1696237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunologic interactions between some inactivated oral vaccines. I. Experiments of the active protection in mice].
    Negretti F
    Ann Sclavo; 1972; 14(5):632-8. PubMed ID: 4592227
    [No Abstract]   [Full Text] [Related]  

  • 39. [The results of experimental and clinical studies of a multicomponent vaccine made of the antigens from opportunistic microorganisms].
    Egorova NB; Efremova VN; Kurbatova EA; Kuz'mina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):96-101. PubMed ID: 9460881
    [No Abstract]   [Full Text] [Related]  

  • 40. [The antigen-specific activity of a multicomponent vaccine administered orally and subcutaneously].
    Mansurova NL; Chuprinina RP; Egorova NB; Kuz'mina LA; Skorikova IG; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):37-9. PubMed ID: 7539974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.